Cargando…

The clinical utility of serum free light chain and heavy/light chain assays in monitoring disease activity in patients with IgG myeloma after achieving a deep response

Heavy/light chain (HLC) assay will enable us to evaluate the changes in the concentrations of iHLC and uHLC separately and to better identify whether the change observed is clonal or reactive. It would therefore aid in decision making for earlier implementation or discontinuation of treatment for pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Kazuyuki, Kamiya, Yoshikazu, Itoh, Junji, Okada, Jun, Lim, Merrell, Sugiyama, Satoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771931/ https://www.ncbi.nlm.nih.gov/pubmed/29375846 http://dx.doi.org/10.1002/ccr3.1304

Ejemplares similares

IgG light chain-independent secretion of heavy chain dimers: consequence for therapeutic antibody production and design
por: Stoyle, Chloe L., et al.
Publicado: (2017)

INDEPENDENT SYNTHESIS OF LIGHT AND HEAVY CHAINS : Quantitation of Light-Chain Production by Mouse Myeloma Variants
por: Laskov, Reuven, et al.
Publicado: (1974)

Bringing the Heavy Chain to Light: Creating a Symmetric, Bivalent IgG-Like Bispecific
por: Ramasubramanian, Anusuya, et al.
Publicado: (2020)

Diagnostic Approach to Glomerulonephritis With Fibrillar IgG Deposits and Light Chain Restriction
por: Kudose, Satoru, et al.
Publicado: (2021)

Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells
por: Joshi, Kamal Kishore, et al.
Publicado: (2019)

Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
por: De Santis, Elena, et al.
Publicado: (2016)

Serum Free Light Chain Only Myeloma with Cytoplasmic IgM
por: Ebana, Hideaki, et al.
Publicado: (2014)

Multiple Myeloma–Associated Ig Light Chain Crystalline Cast Nephropathy
por: Matsumura, Hirotoshi, et al.
Publicado: (2020)

Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma
por: Suehara, Yasuhito, et al.
Publicado: (2017)

Discrete renal deposition of IgM heavy chain and κ light chain in Waldenström macroglobulinemia (IgM-κ)
por: Komatsuda, Atsushi, et al.
Publicado: (2012)

Light chain myeloma and detection of free light chains in serum and urine of dogs and cats
por: Harris, Robert Adam, et al.
Publicado: (2021)

Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients
por: Michallet, M, et al.
Publicado: (2018)

Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease
por: Grados, Aurélie, et al.
Publicado: (2013)

Effect of Fc core fucosylation and light chain isotype on IgG1 flexibility
por: Saporiti, Simona, et al.
Publicado: (2023)

Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
por: Napodano, Cecilia, et al.
Publicado: (2023)

Lambda Light Chain Non-crystalline Proximal Tubulopathy with IgD Lambda Myeloma
por: Kishi, Seiji, et al.
Publicado: (2018)

Axonemal dynein light chain-1 locates at the microtubule-binding domain of the γ heavy chain
por: Ichikawa, Muneyoshi, et al.
Publicado: (2015)

Light Chain Myeloma Precipitating Cryoglobulinemic Vasculitis
por: Saeed, Bilal, et al.
Publicado: (2023)

Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG
por: Fischer, Nicolas, et al.
Publicado: (2015)

Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development
por: Dumet, Christophe, et al.
Publicado: (2019)

Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myeloma
por: Willrich, Maria Alice V., et al.
Publicado: (2022)

Randall-Type Monoclonal IgE Kappa Light-Heavy Chain Deposition Disease
por: Isnard, Pierre, et al.
Publicado: (2023)

The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach
por: Ríos-Tamayo, Rafael, et al.
Publicado: (2021)

Botulinum Neurotoxin Heavy Chain Belt as an Intramolecular Chaperone for the Light Chain
por: Brunger, Axel T, et al.
Publicado: (2007)

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials
por: Lopez-Anglada, Lucia, et al.
Publicado: (2018)

Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
por: Tsushima, Takafumi, et al.
Publicado: (2021)

Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2020)

Light-Chain Multiple Myeloma: A Diagnostic Challenge
por: Silva, Cristina, et al.
Publicado: (2021)

Crystalline light chain cast nephropathy in multiple myeloma
por: Lin, Zi-Shan, et al.
Publicado: (2021)

Multiple myeloma with acute light chain cast nephropathy
por: Leung, Nelson, et al.
Publicado: (2023)

Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response to Therapy
por: Moustafa, Muhamad Alhaj, et al.
Publicado: (2015)

Heavy chain–only antibodies are spontaneously produced in light chain–deficient mice
por: Zou, Xiangang, et al.
Publicado: (2007)

Defective Kinesin Heavy Chain Behavior in Mouse Kinesin Light Chain Mutants
por: Rahman, Amena, et al.
Publicado: (1999)

Multiple myeloma: Detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chains
por: Wilhite, Dorian, et al.
Publicado: (2021)

Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells
Publicado: (1995)

Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern
por: Zeman, David, et al.
Publicado: (2012)

Synthesis of myosin heavy and light chains in muscle cultures
Publicado: (1975)

Idiotypes of inulin-binding myeloma proteins localized to variable region light and heavy chains: genetic significance
Publicado: (1977)

Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients
por: Batinić, Josip, et al.
Publicado: (2015)

Involved/uninvolved heavy/light chain index can predict progression in transplanted multiple myeloma patients
por: Espiño, M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fn50v06i28dphimphgd97m38ao